Kom Op Tegen Kanker
Kom Op Tegen Kanker
Explore linked clinical trials.20 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer | Abdominal Neoplasms, Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Peritoneal Diseases, adenocarcinoma, appendiceal neoplasm, bile duct cancer, bile duct disorder, bile duct neoplasm, biliary tract disorder, carcinoma, cecal disorder, cecal neoplasm, cholangiocarcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, gastric cancer, gastric neoplasm, intestinal disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, peritoneal neoplasm, rectal disorder, stomach disorder | Active, not recruiting | Phase 1 | 2026-07-13 | NCT05277766 | |
| Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Wilms tumor, adenoma, benign urinary system neoplasm, epithelial neoplasm, hereditary disease, hereditary neoplastic syndrome, kidney cancer, kidney disorder, lung disorder, lung neoplasm, malignant mesothelioma, malignant pleural mesothelioma, mesothelial neoplasm, mesothelioma, mixed neoplasm, neoplasm, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2026-06-05 | NCT05765084 | |
| Liquid Biopsies in Esophageal Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, neoplasm | Recruiting | Not applicable | 2026-06-01 | NCT05704530 | |
| PI-targeted PNE+MI Compared to BIOMEDICAL Education in BCS | Chronic Pain, Neoplasms by Site, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not applicable | 2026-05-06 | NCT04730154 | |
| Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer | Adult Type Granulosa Cell Tumor; Low Grade Serous Ovarian Carcinoma | Recruiting | Phase 2 | 2026-05-05 | NCT05872204 | |
| FOLICOLOR TRIAL: Following Therapy Response Through Liquid Biopsy in Metatstatic Colorectal Cancer Patients | Advanced Colorectal Cancer | Recruiting | Phase 3 | 2026-04-30 | NCT07558083 | |
| Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Kennedy disease, Neoplasms by Site, Skin and Connective Tissue Diseases, X-linked disease, breast disorder, breast neoplasm, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, motor neuron disorder, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, skin disorder, spinal cord disorder, spinal muscular atrophy, triple-negative breast carcinoma | Recruiting | Phase 2 | 2026-04-01 | NCT06365788 | |
| Efficacy of Offering a Self-sampling Device by the GP to Reach Underscreened Women | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Active, not recruiting | Not applicable | 2026-02-17 | NCT05656976 | |
| Early Radiotherapy Versus Observation for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases | Asymptomatic or Minimally Symptomatic; Bone Metastases; High Risk for Skeletal Events; Solid Neoplasms | Recruiting | Not applicable | 2026-01-20 | NCT07146074 | |
| NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study | Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenoma, epithelial neoplasm, lung disorder, lung neoplasm, malignant mesothelioma, mesothelial neoplasm, mesothelioma, neoplasm, pleural epithelioid mesothelioma, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-08-13 | NCT07121374 | |
| Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not applicable | 2025-08-08 | NCT06691425 | |
| The Effect of Personalized Exercise Interventions for the Prevention of Chemotherapy-induced Peripheral Neuropathy | Chemotherapy Induced Peripheral Neuropathy (CIPN) | Recruiting | Not applicable | 2025-07-09 | NCT06962579 | |
| ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate Cancer (mCRPC); Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Recruiting | Phase 3 | 2025-04-09 | NCT03903835 | |
| Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, classic familial adenomatous polyposis, digestive system disorder, digestive system neoplasm, esophageal disorder, gastric cancer, gastric neoplasm, neoplasm, pancreatic ductal adenocarcinoma, stomach disorder | Recruiting | Phase 2 / Phase 3 | 2025-02-07 | NCT06782412 | |
| Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer | Muscle-Invasive Bladder Carcinoma | Recruiting | Phase 2 | 2025-01-15 | NCT04724928 | |
| Targeting Fear of Cancer Recurrence in Cancer Survivors: Evaluation of Internet-Based Emotional Freedom Techniques and Internet-Based Mindfulness Meditation as Intervention Strategies | Fear of Cancer Recurrence | Enrolling by invitation | Not applicable | 2024-07-26 | NCT06175208 | |
| Lymphedema After Gyneco-oncologic Treatment | Hemic and Lymphatic Diseases, lymphatic system disorder, lymphedema | Recruiting | Not applicable | 2024-06-20 | NCT05469945 | |
| ASPIRIN Trial Belgium | Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm, rectal disorder | Active, not recruiting | Phase 3 | 2024-03-19 | NCT03464305 | |
| Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission | Disease Attributes, Disease Progression, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Complete Response, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 2 | 2024-03-12 | NCT01686334 | |
| Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate adenocarcinoma, prostate cancer, prostate disorder | Active, not recruiting | Phase 2 | 2023-12-01 | NCT04045717 |